Salute e Benessere
Surgical Sutures Market Worth US$6.65 billion by 2030 with 6.5% CAGR | MarketsandMarkets™
Suture thread dominates the surgical sutures market due to its essential role in wound closure across various surgical procedures. As the core component of any suturing system, it is integral to traditional open surgeries and minimally invasive techniques. The preeminence of suture thread can be attributed to its remarkable versatility, diverse material options, and continuous advancements in design and functionality. Innovations such as non-absorbable, absorbable, antibacterial-coated, and barbed suture threads have expanded their application spectrum across various surgical disciplines, including cardiovascular, orthopedic, gynecologic, and general surgery. Clinicians increasingly opt for threads characterized by high tensile strength, minimal tissue reactivity, and reliable absorption profiles—attributes that leading manufacturers consistently refine to meet the evolving demands of surgical practice.
Multifilament sutures dominate the surgical sutures market due to their superior handling properties, reliable knot security, and broad application across various surgical specialties. These sutures are constructed from multiple braided or twisted filaments, which give them enhanced flexibility and tensile strength compared to their monofilament counterparts. This makes multifilament sutures particularly well-suited for surgical procedures that demand precise tissue closure, as they can adapt more readily to the contours of the tissue being sutured. The intricate design of multifilament sutures allows for better manipulation during surgical procedures, enabling surgeons to achieve a secure and stable closure. The improved knot-holding capability of these sutures is crucial in maintaining the integrity of the surgical site, reducing the risk of complications that can arise from loosening or failure. In high-pressure clinical environments, where time is often of the essence, the ease of handling that multifilament sutures provide can streamline surgical processes, ultimately contributing to shorter operation times and improved patient outcomes. Their versatility and effectiveness have made multifilament sutures a preferred choice among surgeons in numerous fields, including general surgery, orthopedics, and plastic surgery.
, the surgical sutures market is characterized by five key regions: North America , Europe , the Asia Pacific , Latin America , and the Middle East and Africa . North America stands at the forefront of this market, bolstered by its advanced healthcare infrastructure, high surgical throughput, and the presence of leading industry players. The region features a robust network of hospitals, ambulatory surgical centers, and specialty clinics that engage in a wide array of complex surgical procedures—including cardiovascular, orthopedic, and general surgeries—all of which rely heavily on high-performance surgical sutures. Particularly, the US accounts for the largest market share due to its aging demographic, the prevalence of lifestyle-related chronic diseases, and an increasing demand for cosmetic and minimally invasive surgical interventions. Furthermore, North America is a hub for technological innovation, housing major corporations such as Ethicon and Medtronic, which consistently introduce cutting-edge suture materials and methodologies. This includes advancements in antimicrobial and absorbable sutures, which are crucial in improving surgical outcomes and patient safety.
The key players in the global surgical sutures market are Ethicon [Johnson & Johnson Services, Inc.] (US), Medtronic ( Ireland ), B. Braun SE ( Germany ), Advanced Medical Solutions Group Plc (UK), Healthium MedTech Limited ( India ), Boston Scientific Corporation (US) Zimmer Biomet Holdings, Inc. (US), Stryker (US), Smith+Nephew (UK), Conmed Corporation (US), Internacional Farmacéutica S.A. de C.V. ( Mexico ), Corza Medical (US), DemeTECH Corporation (US), Unisur Lifecare Pvt. Ltd ( India ), Assut Europe ( Italy ), RESORBA Medical GmbH ( Germany ), KATSAN Katgüt Sanayi ve Tic. A.S. ( Turkey ), Sutumed Corp. (US), Mellon Medical ( Netherlands ), Futura Surgicare Pvt. Ltd. ( India ), GMD Group ( Turkey ), Lotus Surgicals Pvt Ltd ( India ), BioSintex ( Romania ), Meril Life Sciences Pvt. Ltd. ( India ), and Aqmen Medtech ( India ).
Ethicon, a subsidiary of Johnson & Johnson, is at the forefront of the surgical suture industry and is recognized for its advanced, high-quality products and comprehensive surgical solutions. The company excels in critical areas such as manufacturing infrastructure, extensive research and development capabilities, and a nuanced understanding of surgical requirements, enabling it to create cutting-edge wound closure innovations. Ethicon's suture portfolio is versatile, catering to various surgical disciplines, including orthopedic, gynecological, cardiovascular, and general surgery. This range encompasses absorbable and non-absorbable sutures, barbed sutures, antibacterial-coated options, and specialty sutures designed for specific applications. The company has made significant investments in technological innovation, especially in automated suture production and the development of bioengineered materials to promote optimal healing outcomes. Furthermore, Ethicon places a strong emphasis on surgeon education, offering global training programs aimed at enhancing surgical techniques and improving patient outcomes.
Medtronic stands as a prominent force in the surgical sutures sector, leveraging its extensive expertise in surgical solutions and wound closure technologies. The company's competencies are rooted in its innovative approach to clinical effectiveness, producing a diverse portfolio of sutures that effectively support both conventional and advanced surgical techniques. Renowned for high-performance offerings, Medtronic's sutures emphasize durability, biocompatibility, and ease of handling to cater to various subspecialties, including cardiovascular, gastrointestinal, and general surgery. The company maintains a robust commitment to research and development, focusing on enhancing product performance across a range of sutures, including absorbable, non-absorbable, and barbed varieties designed to meet the dynamic demands of surgical practice. One of Medtronic's significant advantages is its expansive global distribution network, coupled with strong engagement with surgeons, facilitating comprehensive training, education, and clinical support on a worldwide scale. Furthermore, the company strategically utilizes its diverse surgical portfolio to create integrated solutions, often bundling sutures with surgical staplers, energy devices, and ancillary instruments. This approach not only provides value-added offerings to healthcare facilities but also enhances surgical efficiency. With a strategic emphasis on expanding market access in emerging economies and addressing the increasing demand for minimally invasive surgical procedures, Medtronic remains a key and adaptive player within the surgical sutures arena.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/surgical-sutures-market-worth-us6-65-billion-by-2030-with-6-5-cagr--marketsandmarkets-302519491.html